Sun Pharma's arm to commence distribution of its formulation products in India

09 Apr 2019 Evaluate

Sun Pharmaceutical Industries’ wholly owned subsidiary -- Sun Pharma Distributors will commence distributing its formulation products in India from this month in a phased manner on the same terms as was with Aditya Medisales. This phased transition is expected to be fully completed by the first quarter of 2019-20.

In January, the company had announced that distribution related to the company's India domestic formulations business shall be transitioned from Aditya Medisales to its wholly-owned subsidiary.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharma Inds. Share Price

1786.05 -40.05 (-2.19%)
10-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.05
Dr. Reddys Lab 1354.20
Cipla 1470.05
Lupin 2190.50
Zydus Lifesciences 1004.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.